Albion Human Nutrition's (Clearfield, UT) chromium nicotinate glycinate chelate (chromium chelate) has been registered on CAS, a division of the American Chemical Society and an internationally recognized scientific database of chemical substances that scientists and regulatory bodies use when evaluating ingredients for their products. Albion's chromium chelate CAS No. is 1208240-55-4.
Albion Human Nutrition's (Clearfield, UT) chromium nicotinate glycinate chelate (chromium chelate) has been registered on CAS, a division of the American Chemical Society and an internationally recognized scientific database of chemical substances that scientists and regulatory bodies use when evaluating ingredients for their products. Albion's chromium chelate CAS No. is 1208240-55-4.
Chromium chelate is part of Albion's TRAACS range, many of whose ingredients are also registered on CAS. (TRAACS stands for The Real Amino Acid Chelate System. Products in the TRAACS range reflect Albion's patented testing method of the degree of chelation of a mineral amino acid chelate. Albion says that no other mineral amino acid chelate producers validate their products or publish clinical studies on their chelates.)
Albion's chromium chelate is highly bioavailable and well tolerated, and is a safe form. Chromium is one of the key minerals in fighting insulin resistance seen in type 2 diabetics and those with metabolic syndrome.
Balchem’s Newest Launch Optifolin+® Brings Innovation to the Folate Market
November 15th 2024Supplement launches featuring 5-MTHF are on the rise with double digit growth. In this episode of Nutritional Outlook’s podcast, we explore Optifolin+®, a new ingredient in the market that offers essential nutrition from prenatal through adulthood. Join us as we uncover the potential impact of the next evolution in folate, setting the stage for a healthier future.
The Nutritional Outlook Podcast Episode 35: Prioritizing Women's Health Research and Innovation
October 28th 2024On this month's episode of the Nutritional Outlook Podcast, Cepham's founder and president, Anand Swaroop, discusses the company's recent announcement to prioritize women's health research and innovation.